{
  "retracted": false,
  "timestamp": 1559347200000,
  "updates": [
    {
      "timestamp": 1557783782676,
      "identifier": {
        "doi": "10.1016/j.lungcan.2019.04.010"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.lungcan.2019.01.005"
  },
  "journal": "Lung Cancer",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan” [Lung Cancer, 129 (March) (2019) 55–62]"
}
